EUVIMEDEUVIMED entdecken
Crossref

Combinative Therapy with miR-17-Targeting Mesyl Oligonucleotide and Cisplatin Suppresses Tumour Growth and Extends Survival in Drug-Resistant KB-8-5 Xenografts

S. K. Miroshnichenko, A. V. Sen’kova, I. A. Savin, R. Demirel, O. S. Almieva, M. S. Kupryushkin, M. A. Maslov, M. A. Zenkova

Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry · 2026-09 · 20 (3-4) · 276-289

DOI: 10.1134/s1990750826600780 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, online erschienen am 18.11.2026. Verfasst von S. K. Miroshnichenko und 7 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Miroshnichenko, S. K., Sen’kova, A. V., Savin, I. A., Demirel, R., Almieva, O. S., Kupryushkin, M. S., Maslov, M. A., & Zenkova, M. A. (2026). Combinative Therapy with miR-17-Targeting Mesyl Oligonucleotide and Cisplatin Suppresses Tumour Growth and Extends Survival in Drug-Resistant KB-8-5 Xenografts. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, 20(3-4), 276-289. https://doi.org/10.1134/s1990750826600780

Vancouver

Miroshnichenko SK, Sen’kova AV, Savin IA, Demirel R, Almieva OS, Kupryushkin MS, et al. Combinative Therapy with miR-17-Targeting Mesyl Oligonucleotide and Cisplatin Suppresses Tumour Growth and Extends Survival in Drug-Resistant KB-8-5 Xenografts. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry. 2026;20(3-4):276-289. doi:10.1134/s1990750826600780

BibTeX
@article{Miroshnichenko2026,
  author = {Miroshnichenko, S. K. and Sen’kova, A. V. and Savin, I. A. and Demirel, R. and Almieva, O. S. and Kupryushkin, M. S. and Maslov, M. A. and Zenkova, M. A.},
  title = {Combinative Therapy with miR-17-Targeting Mesyl Oligonucleotide and Cisplatin Suppresses Tumour Growth and Extends Survival in Drug-Resistant KB-8-5 Xenografts},
  journal = {Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry},
  year = {2026},
  volume = {20},
  number = {3-4},
  pages = {276--289},
  doi = {10.1134/s1990750826600780}
}
Kostenlos starten →